Repaglinide and voglibose 0.1mg"'"'"'

Repaglinide and voglibose 
RAPIGLINIDE VOG are two antidiabetic medications used in the treatment of type 2 diabetes mellitus. They work through different mechanisms to help manage blood sugar levels.
Here are some key points about RAPIGLINIDE VOG:
Repaglinide: Repaglinide is a medication known as a meglitinide. It stimulates the release of insulin from the pancreas, thereby helping to lower blood sugar levels. Repaglinide is typically taken orally before meals, as it acts rapidly and has a shorter duration of action compared to some other antidiabetic medications. It helps control postprandial (after-meal) blood sugar spikes.
Voglibose: Voglibose is an alpha-glucosidase inhibitor. It works by inhibiting certain enzymes in the intestine that break down carbohydrates, thereby slowing down the absorption of glucose from the digestive system. By reducing the rate of carbohydrate digestion and absorption, voglibose helps control postprandial blood sugar levels.
Combination use: RAPIGLINIDE VOG are sometimes used together in the management of type 2 diabetes. The combination of these medications can provide complementary effects, targeting both insulin release and glucose absorption, to help achieve better glycemic control.
Administration: Repaglinide is available in tablet form and is typically taken orally 15-30 minutes before each main meal. The dosage and frequency of administration will depend on the individual's blood sugar levels and response to the medication. Voglibose is also available in tablet form and is taken orally with meals. The dosage and frequency will be determined by a healthcare professional.
Effectiveness: Repaglinide helps lower blood sugar levels by stimulating insulin release from the pancreas, particularly after meals. Voglibose slows down the absorption of glucose from the digestive system, reducing postprandial blood sugar spikes. When used in combination, they can help improve glycemic control in individuals with type 2 diabetes.
Side effects: Common side effects of repaglinide may include hypoglycemia (low blood sugar), weight gain, and gastrointestinal symptoms such as nausea and diarrhea. Voglibose may cause gastrointestinal disturbances such as flatulence, bloating, and diarrhea. RAPIGLINIDE VOG  is important to report any concerning side effects to a healthcare professional.
Precautions: RAPIGLINIDE VOG  should be used with caution in individuals with certain medical conditions or a history of specific complications. RAPIGLINIDE VOG is important to inform the healthcare professional about all current medications being taken to avoid potential drug interactions.
For further information please contact:
info@sterispharma.com
order now: - https://www.sterisonline.com/product/rapiglinide-vog-1-0-134237